Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
2.960
-0.220 (-6.92%)
Oct 30, 2026, 4:00 PM EDT - Market closed
IMDX Market Cap
IMDX has a market cap or net worth of $96.86 million as of October 30, 2026. It is the 25,247th most valuable company in the world and the 4,112th biggest in the United States. Its market cap has decreased by 42.72% in one year.
Market Cap
96.86M
Enterprise Value
81.73M
1-Year Change
-42.72%
Global Rank
Country Rank
#4,112 United States
Category
ChartMarket Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $96.86M, a decrease of -57.65%. That is a compound annual growth rate of -7.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 96.90M | -54.93% |
| Dec 31, 2025 | 215.00M | 436.16% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 1.24B |
| Castle Biosciences | 1.14B |
| Myriad Genetics | 607.38M |
| Fulgent Genetics | 567.37M |
| Biodesix | 245.37M |
| Exagen | 208.10M |
| Burning Rock Biotech | 114.96M |
| Quantum Cyber | 70.62M |